Results of the antimicrobial agent susceptibility study raised in a representative, cross-sectional monitoring study on a national basis

International Journal of Medical Microbiology

Volumn 296, Issue SUPPL. 2, 2006, Pages 69-79

  Kaspar, Heike ^a  

^a Federal Office of Consumer Protection and Food Safety   (Germany)

Author keywords

Antimicrobial substances; Comprehensive cross sectional study; Minimum inhibitory concentration; Resistance rates

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; AVILAMYCIN; CEFALOTIN; CEFOPERAZONE; CEFTIOFUR; CHLORAMPHENICOL; CLAVULANIC ACID; DALFOPRISTIN; ENROFLOXACIN; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; LINCOMYCIN; OXACILLIN; PENICILLIN G; QUINOPRISTIN; TETRACYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL HEALTH; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; DRUG SENSITIVITY; ESCHERICHIA COLI; HUMAN; LIVESTOCK; MANNHEIMIA HAEMOLYTICA; NONHUMAN; PASTEURELLA MULTOCIDA; RESPIRATORY TRACT DISEASE; SAFETY; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 33646827350     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2006.01.063     Document Type: Article

References (21)

1. Bywater R.J. Sense and nonsense in surveillance programs. Acta Vet. Scand. 93 Suppl. (2000) 119-127
2. Caprioli A., Busani L., Martel J.L., and Helmuth R. Monitoring of antibiotic resistance in bacteria of animal origin: epidemiological and microbiological methodologies. Int. J. Antimicrob. Agents 14 (2000) 295-301
3. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals: Approved Standard M31-A2 (2002), CLSI, Wayne, PA, USA
4. Clinical and Laboratory Standards Institute (CLSI). Development of in vitro susceptibility testing criteria and quality control parameters for veterinary antimicrobial agents: Approved Guideline M37-A2 (2002), CLSI, Wayne, PA, USA
5. Ellner P.D., and Neu H.C. The inhibitory quotient. A method for interpreting minimum inhibitory concentration data. JAMA 246 (1981) 1575-1578
6. Felmingham D. The need for antimicrobial resistance surveillance. J. Antimicrob. Chemother. 50 Suppl. S1 (2002) S1-S7
7. Guerra B., Junker E., Schroeter A., Malorny B., Lehmann S., and Helmuth R. Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry. J. Antimicrob. Chemother. 52 (2003) 489-492
8. Kadlec K., Kehrenberg C., Wallmann J., and Schwarz S. Antimicrobial susceptibility of Bordetella bronchiseptica isolates from porcine respiratory tract infections. Antimicrob. Agents Chemother. 48 (2004) 4903-4906
9. Kahlmeter G., and Brown D.F.J. Resistance surveillance studies - comparability of results and quality assurance of methods. J. Antimicrob. Chemother. 50 (2002) 775-777
10. Kehrenberg C., Mumme J., Wallmann J., Verspohl J., Tegeler R., Kuhn T., and Schwarz S. Monitoring of florfenicol susceptibility among bovine and porcine respiratory tract pathogens collected in Germany during the years 2002 and 2003. J. Antimicrob. Chemother. 54 (2004) 572-574
11. Kresken M., and Hafner D. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Fluorchinolonen (Ciprofloxacin) in Mitteleuropa. Chemotherapie J 20 (2002) 18-24
12. Lewis D. Antimicrobial resistance surveillance: method will depend on objectives. J. Antimicrob. Chemother. 49 (2002) 3-5
13. MacGowan A.P., and Wise R. Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. J. Antimicrob. Chemother. 48 Suppl. S1 (2001) 17-28
14. National Mastitis Council Inc., 1999. Laboratory Handbook on Bovine Mastitis, revised ed. Walton Commons West, WI, USA. http://www.nmconline.last (last accessed 24.11.2005).
15. Phillips I., Casewell M., Cox T., De Groot B., Friis C., Jones R., Nightingale C., Preston R., and Waddell J. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob. Chemother. 53 (2004) 28-52
16. Prescott J.F. Beta-lactam antibiotics: Penam penicillins. In: Prescott J.F., Baggot J.D., and Walker R.D. (Eds). Antimicrobial Therapy in Veterinary Medicine, third ed (2000), Iowa State University Press, Ames, IA, USA 110
17. Salisbury J.G., Nicholis T.J., Lammerding A.M., et al. A risk analysis framework for the long-term management of antibiotic resistance in food-producing animals. Int. J. Antimicrob. Agents 20 (2002) 153-164
18. Schwarz S., Kehrenberg C., Salmon S.A., and Watts J.L. In vitro activities of spectinomycin and comparator agents against Pasteurella multocida and Mannheimia haemolytica from respiratory tract infections of cattle. J. Antimicrob. Chemother. 53 (2004) 379-382
19. Turnidge J. Antibiotic use in animals - prejudices, perceptions and realities. J. Antimicrob. Chemother. 53 (2004) 26-27
20. Walker R.D., and Thornsberry C. Decrease in antibiotic susceptibility or increase in resistance?. J. Antimicrob. Chemother. 41 (1998) 1-4
21. Wallmann J., Schröter K., Wieler L.H., and Kroker R. National antibiotic resistance monitoring in veterinary pathogens from sick food-producing animals: the German program and results from the 2001 pilot study. Int. J. Antimicrob. Agents 22 (2003) 420-428